Optimi Health Corp. (OPTH)
NasdaqCM: OPTH
· Echtzeitkurs · USD
4.75
+0.07 (1.50%)
Zum Schluss: Aug 12, 2026, 3:59 PM
Optimi Health Corp. (OPTH) Stock Price, Analysis & Data
1.50% (1D)
| Geld | 4.65 |
| Marktkapitalisierung | 27.2 Mio |
| Umsatz (TTM) | 231.86K |
| Nettogewinn (TTM) | -5.4 Mio |
| Beta | 1.60 |
| EPS (ttm) | -1.25 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 6.09 |
| KUV (TTM) | 117.30 |
| Earnings Date | n/a |
| Brief | 4.73 |
| Volumen | 7,329 |
| Ø Vol. (20D) | 156,596 |
| Eröffnung | 4.87 |
| Vortagesschluss | 4.68 |
| Tagesspanne | 4.55 - 4.87 |
| 52-Wk Range | 4.00 - 6.40 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über OPTH
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical source...
Sektor Healthcare
IPO Datum May 20, 2026
Mitarbeiter n/a
Börse NasdaqCM
Tickersymbol OPTH
Website https://www.optimihealth.ca
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Optimi Health 426.3K, ein Anstieg von 9.35% im Vergleich zum Vorjahr (389.85K). Der Gewinn lag bei -3.71 Mio, ein Rückgang von -38.5 %.
Finanzberichte
